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Background: Endometriosis occurring in surgical scars is a well-described entity. Malignant
transformation of endometriosis is a rare event, with most cases belonging to adenocar-
cinoma. The initial surgical treatment is a method of choice. Due to lack of therapeutic
recommendations, adjuvant therapy and recurrence management are a great challenge for
oncologists.
Aim:The aimof this paperwas to present a long-term survival as the outcome ofmultimodal
therapy in the patient with recurrent adenocarcinoma arising from Caesarean section scar
endometriosis.
Case: We present the case of a woman with recurrent adenocarcinoma arising from Cae-
sarean section scar endometriosis. The disease was ﬁrst diagnosed in September 1997 at
age 43. The patient underwent abdominal hysterectomy with tumour excision. Due to a
local recurrence after 4 years, tumour excision with abdominal wall repair using a plastic
mesh, regional lymphadenectomy, bilateral salpingo-ovariectomy and adjuvant radiother-
apy for the pelvic region with local boost were performed; in addition hormontherapy with
medroxyprogesterone was started. Because of a recurrent pelvic tumour, chemotherapy,
further local palliative radiotherapy and brachytherapy were administered. Subsequently
distantmetastases in bilateral axillary lymphnodeswerediagnosedandpalliative radiother-
apy was performed. The patient died of morbus neoplasmaticus generalisatus in September2008. The follow-up period had been 132 months.
Conclusion: This paper is, to our knowledge, the only report in literature that presents a long-
term survival as the outcome of multimodal therapy in the patient with this rare diagnosis.
Further reports of new cases can help establish optimal treatment guidelines.
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1. Introduction
Endometriosis, which means the presence of endome-
trial tissue outside the uterus, can be seen in intra- and
extraabdominal localisations. In the abdominal wall it can
occur after hysterectomies, particularly after Caesarean
sections.1–4 Malignant transformation of endometriosis, espe-
cially abdominal wall endometriosis, is a rare event.5,6 In the
literature we have found only a few reports concerning this
diagnosis.7–18 We present a new case of recurrent adenocarci-
noma arising from Caesarean section scar endometriosis.
2. Case report
The disease was ﬁrst diagnosed in September 1997 at age
43. In 1980 the patient had delivery with caesarean sec-
tion. After 17 years she developed hypogastric pain and an
extensive lesion of endometriotic type with pressure on the
left inguinal region. The post-caesarean scar tumour was
removed and a hysterectomy without adnexa was performed
with specimens fromboth ovaries obtained. Histopathological
examination revealed papillary endometrioid adenocarci-
noma in the abdominal wall tumour, with no changes in the
ovary and the uterus. The adenocarcinoma focuswas probably
removed within normal tissue boundaries.
After 4 years (December 2001) recurrence in the left
inguinal region was observed. The tumour with lymph nodes
around left iliac vesselswas excised and ameshwas sewn into
the abdominalwall defect. The histopathological examination
of the tumour revealed adenocarcinoma endometroides G2
and reactive lymph nodes. The adnexa were removed bilat-
erally 2 months later, the histopathologic report revealed no
pathology.
In 2002 due to disease progression in the soft tissues of the
pubic region, radical irradiation was instituted. The patient
received 45Gy in 25 fractions with photon beam 10MeV for
the whole pelvis and a boost of 10Gy in 5 fractions with
electron beam 14MeV on the area of enlarged right inguinal
lymph nodes. Additionally the treatment involved intramus-
cular Depo-Provera injections of 500mg twice a week, which
were continued for 14 months.
In 2006 right inguinal pain had its onset. The exami-
nations performed revealed high CA-125 values; in the CT
pelvic scan of the pre-pubic region a mixed-density tumour
13 cm×9 cm causing pubic bone destruction and pressing on
the urinary bladder. Nine cycles of chemotherapy of the PAC
regimen (cyclophosphamide, cisplatin, doxorubicin) and one
cycle of the VFP regimen (cisplatin, etoposide, 5-ﬂuorouracil)
were delivered. Because of a ischaemic stroke which occurred
after last cycle, the chemotherapy was stopped. Subsequently,
due to increasing hydronephrosis right nephrostomy was per-
formed.
We saw the patient after 8 months with local bleeding from
the tumour in the right pubic inguinal. Palliative irradiation of
the lesion with 15Gy dose in 5 fractions was administered,
followed by intratissue radiation therapy PDR dose of 10Gy in
10 pulses every hour, encompassing the inguinal tumour pole.diotherapy 1 5 ( 2 0 1 0 ) 75–77
In April 2008 the patient reported with painful packets of
enlarged lymph nodes – in the right axilla to 5 cm, in the left
axilla – to 8 cm. Histopathological examination of the right
axilla revealed cellulae carcinomatosae. Palliative irradiation
of both axillary areas was instituted, with the dose of 20Gy in
5 fractions, thus obtaining clinical improvement.
The patient died on 10 September, 2008 of generalized neo-
plastic disease.
3. Discussion
Endometriosis is a frequently occurring disease in women of
reproductive age. It is usually located inside the pelvis and
can be found in the uterus, ovaries, oviducts and peritoneum.
Extrapelvic endometriosis is rare, but there are reports of
endometriosis in almost all localisations like kidneys, lungs,
CNS, etc.3 In the abdominal wall endometriosis can be seen in
the umbilicus or in surgical scars, particularly after Caesarean
sections (0.03–0,45%)1–4 and various surgical procedures (other
hysterotomies, amniocentesis). Abdominal wall endometri-
oma is associated with pelvic endometriosis in 14–26% of
cases.4,19 Wide local excision, frequently associated with
abdominal wall repair using a plastic mesh, is a method of
choice.2,4,20
Malignant transformation of endometriosis is an infre-
quent event. It affects 0.3–1% of women suffering from
endometriosis.5,6 A case of cancer arising in ectopic endome-
trial tissue was ﬁrst reported in 1925 in the ovary,21 which
is the most frequent location for this unusual disease, the
remainder occurs in extragonadal sites.5 The histopathologic
types of malignant transformations of endometriosis belong
in most cases to endometrioid carcinoma (adenocarcinoma)
– 69%, followed by sarcoma (25%), clear cell carcinoma (4.5%)
and others.5
The diagnosis of primary adenocarcinoma in extraabdomi-
nal endometriosis requires fulﬁllment of Sampson’s criteria21:
1. endometriosis in close proximity to the tumour;
2. no other primary carcinoma should be identiﬁed;
3. the histology should be compatible with an endometrial
origin.
In our case the ﬁrst criterion was not fulﬁlled (the
pathologic report does not mention endometriosis in close
proximity to the tumour). The reason could be that the tumour
may have destroyed the primary focus of endometriosis.18
An interesting issue is thedelay betweenCaesarean section
and diagnosis of malignant transformation of endometriosis
located in the abdominal scar. The true endometriosis – a
benign tissue – occurs in Caesarean section scars after 7–35
months,19 but it can also be seen later up to 20 years.1,4 In the
contrary the malignant tissue develops after 3–39 years7–18;
17 years in our case. This supports the thesis that malignant
transformation is a long-term process.
In the literature we have found only a few reports10–18 and
short reviews7–9 concerning malignancies arising from Cae-
sarean scar endometriosis. They present cases of patients
suffering from clear cell carcinoma, endometrioid carcinoma
(adenocarcinoma) and one case of carcinosarcoma. The onset
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ge was 38–60. In all cases the initial treatment was radi-
al resection, mostly with plastic mesh for abdominal wall
econstruction. In most cases the surgical treatment also
ncluded total hysterectomy with adnexectomy or diagnos-
ic curettage. The approach to adjuvant therapy was variable.
here were cases with no adjuvant treatment, but in the most
atients adjuvant therapy was administered. It consisted of
hole pelvis and scar radiotherapy, chemotherapy (various
rotocols including: carboplatin, cyclophosphamide, pacli-
axel, cisplatin, doxorubicin), hormontherapy (progesterone,
edroxyprogesterone). In one case a second line chemother-
py was performed (gemcitabine, mitoxantrone). There was
o report concerning recurrence.
In our case the initial radical surgical treatment was com-
licated by a local and pelvic recurrence after 4 years. It
emanded further treatment, primarily surgical followed by
adiotherapy, hormontherapy and chemotherapy.
In the reported cases the follow-upperiodswere short (2–60
onths) due to early deaths from disease (6–20 months) or no
vidence of disease. In our case the follow-up period had been
32 months.
. Conclusions
his paper is, to our knowledge, the only report in literature
hich presents a long-term survival as the outcome of mul-
imodal therapy in the patient with this rare diagnosis. As
he number of Caesarean sections increases, further reports
f new cases are necessary to establish optimal treatment
uidelines.
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